{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Free Realtime Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "currency": "SEK", "esgPopulated": false, "market": "se_market", "longName": "Isofol Medical AB (publ)", "marketState": "REGULAR", "regularMarketPrice": 0.594, "messageBoardId": "finmb_47549518", "exchange": "STO", "shortName": "Isofol Medical AB", "exchangeTimezoneShortName": "CEST", "exchangeTimezoneName": "Europe/Stockholm", "regularMarketChangePercent": 9.796668, "gmtOffSetMilliseconds": 7200000, "fiftyTwoWeekLowChange": 0.09799999, "fiftyTwoWeekLowChangePercent": 0.19758064, "fiftyTwoWeekRange": "0.496 - 10.1", "fiftyTwoWeekHighChange": -9.5060005, "fiftyTwoWeekHighChangePercent": -0.94118816, "fiftyTwoWeekLow": 0.496, "fiftyTwoWeekHigh": 10.1, "earningsTimestamp": 1683111540, "earningsTimestampStart": 1683111540, "earningsTimestampEnd": 1683111540, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.97, "epsForward": -0.05, "firstTradeDateMilliseconds": 1491289200000, "priceHint": 4, "regularMarketChange": 0.052999973, "regularMarketTime": 1684143408, "regularMarketDayHigh": 0.594, "regularMarketDayRange": "0.54 - 0.594", "regularMarketDayLow": 0.54, "regularMarketVolume": 429463, "regularMarketPreviousClose": 0.541, "bid": 0.576, "ask": 0.593, "bidSize": 0, "askSize": 0, "fullExchangeName": "Stockholm", "financialCurrency": "SEK", "regularMarketOpen": 0.54, "averageDailyVolume3Month": 801695, "averageDailyVolume10Day": 1356368, "sharesOutstanding": 161515008, "bookValue": 0.981, "fiftyDayAverage": 0.58448, "fiftyDayAverageChange": 0.009519994, "fiftyDayAverageChangePercent": 0.016287973, "twoHundredDayAverage": 0.81065, "twoHundredDayAverageChange": -0.21665001, "twoHundredDayAverageChangePercent": -0.26725468, "marketCap": 104274920, "forwardPE": -11.879999, "priceToBook": 0.6055046, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "5.0 - Sell", "tradeable": false, "cryptoTradeable": false, "symbol": "ISOFOL.ST"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Biotech Center", "address2": "Arvid Wallgrens Backe 20", "city": "Gothenburg", "zip": "413 46", "country": "Sweden", "phone": "46 3 17 97 22 80", "website": "https://isofolmedical.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Isofol Medical AB (publ), a clinical stage biotech company, develops, commercializes, and sells oncology drugs in Sweden and internationally. The company develops arfolitixorin, which is in phase 3 clinical trial for the treatment of advanced colorectal cancer. It has strategic collaborations with Recipharm. The company was incorporated in 2008 and is headquartered in Gothenburg, Sweden.", "fullTimeEmployees": 13, "companyOfficers": [{"maxAge": 1, "name": "Mr. Thomas  Andersson Ph.D.", "age": 70, "title": "Chief Exec. Officer", "yearBorn": 1952, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Roy  Jonebrant", "title": "Acting Chief Financial Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Roger  Tell M.D., Ph.D.", "age": 57, "title": "Chief Medical Officer, Chief Scientific Officer & Sr. VP of Clinical Devel.", "yearBorn": 1965, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}